The correlation between the up-regulation of Hsp90 and drug resistance to cisplatin in lung cancer cell line

Chinese Journal of Lung Cancer

Volumn 14, Issue 6, 2011, Pages 472-477

  Liu, Ting ^a   Wang, Xiaokun ^a   Zhang, Lichuan ^a  

^a DALIAN UNIVERSITY   (China)

Author keywords

Drug resistance; GGA; Hsp90; Lung neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; HEAT SHOCK PROTEIN 90; TEPRENONE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; IC 50; IMMUNOFLUORESCENCE; LUNG CANCER; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; UP-REGULATION;

EID: 79958697697     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.06.02     Document Type: Article

References (30)

1. Tomida A, Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des, 1999, 14(2): 169-177.
2. Jolly C, Morimoto RI. Role of the heat shock response and molecular Chaperones in oncogenesis and cell death. J Natl Cancer Inst, 2000, 92(19): 1564-1572.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000, 100(1): 57-70.
4. Gress TM, Muller-Pillasch F, Weber C, et al. Differential expression of heat shock proteins in human pancreatic carcinoma. Cancer Res, 1994, 54(2): 547-551.
5. Yano M, Naito Z, Tanaka S, et al. Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res, 1996, 87(9): 908-915.
6. Liu XL, Ye L, Wang JB, et al. Expression of heat shock proteins 90β in human gastric cancer cell lines. J Fourth Milit Med Univ, 2000, 21(2): 131-134.
7. Chen Y, Ding J. Heat shock protein 90-Novel target for cancer therapy. Ai Zheng, 2004, 23(8): 968-974.
8. Sreedhar AS, Soti C, Csermely P. Inhibition of Hsp90: a new strategy for inhibiting protein kinases. Biochim Biophys Acta, 2004, 1697(1/2): 233-242.
9. Liu MJ. The expression and clinical significance of heat shock protein 70 and 90 in acute leukemia cells [D]. Shijiazhuang: Hebei Medical University, 2005.
10. Endo S, Hiramatsu N, Hayakawa K, et al. Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSP70), elicits unfolded protein response and coordinates cellular fate independently of HSP70. Mol Pharmacol, 2007, 72(5): 1337-1348.
11. Basso AD, Solit DB, Chiosis G, et al. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Biol Chem, 2002, 277(42): 39858-39866.
12. Robert J. Evolution of heat shock protein and immunity. Dev Comp Immnol, 2003, 27(6/7): 449-464.
13. Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytoehrome c-mediated oligomerization of Apaf-1and activation of proeaspase-9 by heat shock protein 90. EMBO J, 2000, 19(16): 4310-4322.
14. Blagosklonny MV, Toretsky J, Bohen S, et al. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc Natl Acad Sci USA, 1996, 93(16): 8379-8383.
15. Zhao C, Wang E. Heat shock protein 90 suppresses tumornecrosis factor induced apoptosis by preventing thecleavage of Bid in NIH3T3 fibroblasts. Cell Signal, 2004, 16(3): 313-321.
16. Sato S, Fujita N, Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA, 2000, 97(20): 10832-10837.
17. Ikeyama S, Kusumoto K, Miyake H, et al. A non-toxic heat shock protein 70 inducer, geranylgeranylacetone, suppresses apoptosis of cultured rat hepatocytes causedby hydrogen peroxide and ethanol. J Hepatol, 2001, 35(1): 53-61.
18. Bai J, Nakamura H, Hattori I, et al. Thioredoxin suppresses 1-methyl-4- phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci Lett, 2002, 321(1/2): 81-84.
19. Nishida T, Matsura T, Nakada J, et al. Geranylgeranylacetone protects against acetaminophen induced hepatotoxicity by inducing heat shock protein 70. Toxicology, 2006, 219(1/3): 187-196.
20. Katsuno M, Sang C, Adachi H, et al. Pharmacological induction of heatshock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci USA, 2005, 102(46): 16801-16806.
21. Matin KJ, Kritzman BM, Price LM, et al. Lingking gene expression patterns to therapeutic groups in breast cancer. Cancer Res, 2000, 60(8): 2232-2238.
22. Conroy SE, Latchman DS. Do heat shock proteins have a role in breast cancer. Br J Cancer, 1996, 74(5): 717-721.
23. Kawanishi K, Shiozaki H, Doki Y, et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer, 1999, 85(8): 1649-1657.
24. Jameel A, Skilton RA, Campbell TA, et al. Clinnical and biological significance of HSP89a in human breast cancer. Int J Cancer, 1992, 50(3): 409-415.
25. Ciocca DR, Fuqua SA, Loek-Lim S, et al. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res, 1992, 52(13): 3648-3654.
26. Liu SQ, Yu JP, Yu HG, et al. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Dig Liver Dis, 2006, 38(5): 310-318.
27. Lin ZY, Chuang WL, Chuang YH, et al. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique. J Gastroenterol Hepatol, 2006, 21(2): 398-405.
28. Kim R, Emi M, Tanabe K, et al. Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations. Anticancer Drugs, 2003, 14(9): 715-723.
29. Yu XC. The role of heat shock protein on the cell apoptosis. J Cell Biol, 2005, 27(1): 1-4.
30. Creagh EM, Sheehan D, Cotter TG. Heat shock proteins-modulators of apoptosis in tumor cells. Leukemia, 2000, 14(7): 1161-1173.